Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes.
Eleanor M. Perfetto, PhD
Advertisement
Articles by Eleanor M. Perfetto, PhD
Eleanor Perfetto, PhD, explores how most favored nation policy relates to broader drug pricing and cost-effectiveness debates in the US.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
2
First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA
3
5 Notable Oncology FDA Approvals Granted in May
4
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
5